NPI: 1942620976 · MENIFEE, CA 92586 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/17/2014
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/17/2014 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 20,281 | $861K |
| 2019 | 29,337 | $1.25M |
| 2020 | 31,850 | $1.38M |
| 2021 | 33,214 | $1.45M |
| 2022 | 32,020 | $1.29M |
| 2023 | 34,409 | $1.59M |
| 2024 | 27,213 | $1.78M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90945 | 140,240 | 5,028 | $8.74M | |
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 17,631 | 748 | $614K |
| A4657 | Syringe, with or without needle, each | 2,633 | 2,520 | $98K |
| 0250 | 4,178 | 2,180 | $86K | |
| 82728 | 3,821 | 3,692 | $18K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 11,011 | 3,472 | $15K |
| 90993 | 77 | 26 | $14K | |
| 82570 | 2,512 | 1,188 | $6K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 660 | 390 | $3K |
| J1756 | Injection, iron sucrose, 1 mg | 3,438 | 2,903 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 915 | 899 | $2K |
| 90662 | 28 | 28 | $926.50 | |
| 85041 | 3,597 | 3,489 | $872.15 | |
| 83540 | 3,799 | 3,669 | $813.69 | |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 537 | 500 | $778.48 |
| 90661 | 15 | 15 | $486.42 | |
| 83970 | 3,807 | 3,681 | $160.37 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,598 | 1,263 | $94.69 |
| 83550 | 3,199 | 3,074 | $30.82 | |
| 85048 | 3,601 | 3,491 | $7.50 | |
| 84540 | 693 | 570 | $3.43 | |
| 90674 | 200 | 190 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 134 | 134 | $0.00 |